We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCVT icon
5201
First Trust SSI Strategic Convertible Securities ETF
FCVT
$101M
-175
Closed -$7K
FDIS icon
5202
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.73B
-15,514
Closed -$962K
FENG
5203
Phoenix New Media
FENG
$18.5M
-377
Closed -$3K
FEZ icon
5204
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.54B
-678
Closed -$25K
FFTY icon
5205
CapForce IBD 50 ETF
FFTY
$78.9M
-18,668
Closed -$696K
FGNX
5206
FG Nexus Inc
FGNX
$41.7M
-45
Closed -$22K
FHLC icon
5207
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
$0 ﹤0.01%
2
FINV
5208
FinVolution Group
FINV
$1.11B
-15,571
Closed -$29K
FMAT icon
5209
Fidelity MSCI Materials Index ETF
FMAT
$621M
-6,974
Closed -$240K
FNCL icon
5210
Fidelity MSCI Financials Index ETF
FNCL
$2.41B
-1,214
Closed -$41K
FNDE icon
5211
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.1B
-218
Closed -$5K
FNGD icon
5212
MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038
FNGD
$317M
0
FWDI
5213
Forward Industries Inc
FWDI
$313M
-29
Closed
FORTY
5214
Formula Systems
FORTY
$1.65B
-6
Closed
FPX icon
5215
First Trust US Equity Opportunities ETF
FPX
$1.48B
-11,540
Closed -$1.11M
FSI icon
5216
Flexible Solutions
FSI
$63.5M
-2,162
Closed -$4K
FTAI icon
5217
FTAI Aviation
FTAI
$22.1B
-848
Closed -$12K
FTXG icon
5218
First Trust Nasdaq Food & Beverage ETF
FTXG
$18.2M
-12
Closed
FTXH icon
5219
First Trust Nasdaq Pharmaceuticals ETF
FTXH
$966M
-42
Closed -$1K
FTXO icon
5220
First Trust Nasdaq Bank ETF
FTXO
$316M
-16,182
Closed -$274K
FVD icon
5221
First Trust Value Line Dividend Fund
FVD
$8.35B
-29,971
Closed -$943K
FXA icon
5222
Invesco CurrencyShares Australian Dollar Trust
FXA
$97.8M
$0 ﹤0.01%
1
FXD icon
5223
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$274M
$0 ﹤0.01%
1
-41,653
-100% -$1.95M
FXG icon
5224
First Trust Consumer Staples AlphaDEX Fund
FXG
$229M
-841
Closed -$40K
FXH icon
5225
First Trust Health Care AlphaDEX Fund
FXH
$1.12B
-31,710
Closed -$3M

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.